Drug Enforcement Administration (DEA) has proposed permanent rules for prescribing controlled medications through telemedicine, which were established during the coronavirus disease 2019 pandemic. The proposed rules address telemedicine consultations by a medical practitioner who has never conducted an in-person evaluation of a patient and that would result in the prescribing of a controlled medication. Under […]

Read More ›

Food and Drug Administration (FDA) published a notice that the guidance documents addressing the coronavirus disease 2019 (COVID-19) public health emergency (PHE) will no longer be effective after the PHE declaration ends on May 11, 2023. This notice will affect 72 COVID-19-related guidance documents. The agency is expected to monitor and assess the circumstances of […]

Read More ›

A specialty pharmacy recently reported look- and sound-alike concerns with Ilaris® (canakinumab), an interleukin-1 beta inhibitor used for Still’s disease, periodic fever syndromes, and systemic juvenile idiopathic arthritis; and Ilumya® (tildrakizumab), an interleukin-23 inhibitor used for plaque psoriasis. Product similarities increase the risk of mix-ups. Both brand names start with the letters “I-L,” and both […]

Read More ›

Centers for Disease Control and Prevention (CDC) published a Morbidity and Mortality Weekly Report on December 16, 2022, which recorded a 109% increase in overdose deaths involving persons aged 10-19 years from July-December 2019 to July-December 2021. Over the same period, the same age group showed a 182% increase in deaths from illicitly manufactured fentanyl. […]

Read More ›

The Office of National Drug Control Policy (ONDCP) piloted a national data dashboard, called the Opioid Overdose Tracker, which tracks the rate of nonfatal opioid overdoses. The program utilizes emergency medical services (EMS) patient care reports and maps them across all 50 states, three territories (Virgin Islands, Guam, and Northern Mariana Islands), and the District […]

Read More ›

The information published in this column was provided by the Healthcare Distribution Alliance (HDA) Pharmaceutical Cargo Security Coalition (PCSC). HDA PCSC is warning the pharmacy industry of a recall fraud incident involving the drug product oxycodone hydrochloride. PCSC notes that the emails/faxes that are claimed to originate from a legitimate pharmaceutical distributor state the following: […]

Read More ›

When Food and Drug Administration (FDA) enacted the Drug Supply Chain Security Act (DSCSA) in 2013, it set a 10-year timeline for full implementation. November 2023 marks the end of that timeline. A significant portion of this last milestone requires the entire supply chain to become interoperable using secure and electronic means. One requirement that […]

Read More ›

The Pharmacy Technician Certification Board (PTCB) has created a new Regulatory Compliance Certificate to provide technicians with the opportunity to demonstrate their knowledge and proficiency regarding pharmacy laws, regulations, legal requirements, and practice standards to maintain compliance and quality assurance in various practice settings. Eligible candidates must hold an active PTCB Certified Pharmacy Technician certification […]

Read More ›

Food and Drug Administration (FDA) launched a new initiative, Supplement Your Knowledge, to help educate, inform, and broaden consumer, educator, and health care professionals’ understanding of dietary supplements. More than half of all Americans take dietary supplements daily or on occasion. The Supplement Your Knowledge resources will provide reliable information about the potential benefits and […]

Read More ›

Gabapentin, a prescription drug approved by Food and Drug Administration to treat seizures and the pain of shingles, was a factor in about one in 10 United States overdose deaths between 2019 and 2020. Gabapentin is used by some consumers to maximize the effects of opioids but can lead to breathing difficulties when used with […]

Read More ›